期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 201, 期 10, 页码 1677-1687出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20042081
关键词
-
资金
- NIAID NIH HHS [R01 AI043477] Funding Source: Medline
- NIEHS NIH HHS [R01 ES006376] Funding Source: Medline
Transcription factor, nuclear factor kappa B (NF-kappa B), is required for osteoclast formation in vivo and mice lacking both of the NF-kappa B p50 and p52 proteins are osteopetrotic. Here we address the relative roles of the two catalytic subunits of the I kappa B kinase (IKK) complex that mediate NF-kappa B activation, IKK alpha and IKK beta, in osteoclast formation and inflammation-induced bone loss. Our findings point out the importance of the IKK beta subunit as a transducer of signals from receptor activator of NF-kappa B ( RANK) to NF-kappa B. Although IKK alpha is required for RANK ligand-induced osteoclast formation in vitro, it is not needed in vivo. However, IKK beta is required for osteoclastogenesis in vitro and in vivo. IKK beta also protects osteoclasts and their progenitors from tumor necrosis factor alpha-induced apoptosis, and its loss in hematopoietic cells prevents inflammation-induced bone loss.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据